G
Greenphire
Greenphire : Payment Technology Solutions for Clinical Trials
About Greenphire
Greenphire is a prominent company specializing in financial lifecycle management solutions for clinical trials. Founded in 2008, Greenphire has established itself as a leader in automating financial processes and data workflows for clinical research. The company serves a diverse range of clients, including pharmaceutical companies, contract research organizations (CROs), and clinical trial sponsors. These clients operate in the global clinical research market, which involves conducting studies to test new medical treatments and drugs.
Greenphire's business model revolves around providing a suite of software solutions that streamline financial operations in clinical trials. This includes everything from budgeting and payment processing to financial analysis and reporting. By automating these processes, Greenphire helps its clients reduce administrative burdens, improve visibility into financial operations, and accelerate payment cycles. This, in turn, allows clinical trial teams to focus more on patient care and less on financial management.
The company makes money by offering its software solutions on a subscription basis, charging clients for access to its platform and services. Additionally, Greenphire may generate revenue through implementation fees and ongoing support services.
Greenphire's solutions are designed to maximize financial transparency, control, and predictability throughout the clinical trial process. This is achieved by providing tools that simplify workflows, enhance data accuracy, and offer comprehensive financial insights. The company's focus on innovation and continuous improvement has made it a trusted partner for industry leaders worldwide.
In summary, Greenphire is dedicated to transforming the financial management of clinical trials, making the process more efficient and effective for all stakeholders involved.
Source: Dealroom company dataInvestors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later1 investor entered at this stage
Thoma Bravo
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
5 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Greenphire on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Greenphire on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

